Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | Leukemia immune evasion in relapse after haploidentical hematopoietic cell transplantation

Pier Edoardo Rovatti • 1 Sep 2020
EBMT 2020
Acute Myeloid Leukemia Leukemia

Pier Edoardo Rovatti, MD, IRCCS San Raffaele Scientific Institute, Milan, Italy, discusses mechanisms of leukemia immune evasion and their role in relapse after haploidentical hematopoietic cell transplantation. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Pier Edoardo Rovatti

7:59
CD3 x CD33 bispecific antibodies redirect donor T-cells against HLA loss
Pier Edoardo Rovatti • 1 Sep 2020
7:59
CD3 x CD33 bispecific antibodies redirect donor T-cells against HLA loss
Pier Edoardo Rovatti • 1 Sep 2020

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals